These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis. Papadopoulou-Marketou N; Chrousos GP; Kanaka-Gantenbein C Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27457509 [TBL] [Abstract][Full Text] [Related]
3. Markers of and risk factors for the development and progression of diabetic kidney disease. Macisaac RJ; Ekinci EI; Jerums G Am J Kidney Dis; 2014 Feb; 63(2 Suppl 2):S39-62. PubMed ID: 24461729 [TBL] [Abstract][Full Text] [Related]
4. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients. Steinke JM; Mauer M; Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710 [TBL] [Abstract][Full Text] [Related]
5. Normoalbuminuric diabetic kidney disease. Chen C; Wang C; Hu C; Han Y; Zhao L; Zhu X; Xiao L; Sun L Front Med; 2017 Sep; 11(3):310-318. PubMed ID: 28721497 [TBL] [Abstract][Full Text] [Related]
10. Update of pathophysiology and management of diabetic kidney disease. Lin YC; Chang YH; Yang SY; Wu KD; Chu TS J Formos Med Assoc; 2018 Aug; 117(8):662-675. PubMed ID: 29486908 [TBL] [Abstract][Full Text] [Related]
11. Role of new biomarkers for the diagnosis of nephropathy associated with diabetes type 2. Żyłka A; Gala-Błądzińska A; Rybak K; Dumnicka P; Drożdż R; Kuśnierz-Cabala B Folia Med Cracov; 2015; 55(4):21-33. PubMed ID: 26867117 [TBL] [Abstract][Full Text] [Related]
12. Beta-2-microglobulin (B2M) expression in the urinary sediment correlates with clinical markers of kidney disease in patients with type 1 diabetes. Monteiro MB; Thieme K; Santos-Bezerra DP; Queiroz MS; Woronik V; Passarelli M; Machado UF; Giannella-Neto D; Oliveira-Souza M; Corrêa-Giannella ML Metabolism; 2016 Jun; 65(6):816-24. PubMed ID: 27173460 [TBL] [Abstract][Full Text] [Related]
13. New insights into the use of biomarkers of diabetic nephropathy. Jha JC; Jandeleit-Dahm KA; Cooper ME Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461 [TBL] [Abstract][Full Text] [Related]
16. Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk. Scilletta S; Di Marco M; Miano N; Filippello A; Di Mauro S; Scamporrino A; Musmeci M; Coppolino G; Di Giacomo Barbagallo F; Bosco G; Scicali R; Piro S; Purrello F; Di Pino A Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238622 [TBL] [Abstract][Full Text] [Related]
17. [Early detection of diabetic nephropathy]. Murussi M; Murussi N; Campagnolo N; Silveiro SP Arq Bras Endocrinol Metabol; 2008 Apr; 52(3):442-51. PubMed ID: 18506269 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of hsa-miR-100-5p May Be a Protective Factor in the Early Stages of Nephropathy in Type 1 Diabetes Mellitus. Pinheiro AHG; Pereira BO; Silva LSD; Melo FTC; Souza ACCB; Leal VSG; Figueiredo PBB; Neto JFA; Santos MCD; Queiroz NNM; Felício KM; Ribeiro-Dos-Santos Â; Felício JS; Cavalcante GC Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891851 [TBL] [Abstract][Full Text] [Related]
19. [Research status and prospect of novel biomarkers for diabetic kidney disease]. Feng ST; Wang B; Liu BC Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(10):691-694. PubMed ID: 33721945 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic challenges of diabetic kidney disease. Vučić Lovrenčić M; Božičević S; Smirčić Duvnjak L Biochem Med (Zagreb); 2023 Oct; 33(3):030501. PubMed ID: 37545693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]